CONTI, Pio
 Distribuzione geografica
Continente #
NA - Nord America 9.154
AS - Asia 6.065
EU - Europa 5.936
SA - Sud America 619
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 7
Totale 21.882
Nazione #
US - Stati Uniti d'America 8.959
SG - Singapore 2.301
CN - Cina 1.747
UA - Ucraina 1.054
IE - Irlanda 834
GB - Regno Unito 792
TR - Turchia 782
SE - Svezia 697
RU - Federazione Russa 628
IT - Italia 552
BR - Brasile 516
VN - Vietnam 487
DE - Germania 482
FR - Francia 464
IN - India 383
FI - Finlandia 224
CA - Canada 122
HK - Hong Kong 80
BD - Bangladesh 56
AR - Argentina 55
MX - Messico 46
PL - Polonia 43
ES - Italia 37
KR - Corea 37
ZA - Sudafrica 34
JP - Giappone 33
BE - Belgio 31
CZ - Repubblica Ceca 31
IQ - Iraq 25
IL - Israele 17
IR - Iran 17
EU - Europa 14
NL - Olanda 14
EC - Ecuador 13
ID - Indonesia 12
UZ - Uzbekistan 12
CL - Cile 11
KE - Kenya 11
LT - Lituania 11
PK - Pakistan 10
SA - Arabia Saudita 10
RO - Romania 9
TN - Tunisia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
EG - Egitto 7
JM - Giamaica 7
CO - Colombia 6
PH - Filippine 6
AU - Australia 5
DZ - Algeria 5
MY - Malesia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GR - Grecia 4
JO - Giordania 4
MA - Marocco 4
MD - Moldavia 4
OM - Oman 4
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
ML - Mali 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EE - Estonia 2
GY - Guiana 2
IM - Isola di Man 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
MM - Myanmar 1
NG - Nigeria 1
Totale 21.871
Città #
Singapore 1.687
Chandler 1.130
Jacksonville 1.113
San Jose 1.028
Dublin 824
Southend 531
Ashburn 526
Dallas 423
Beijing 393
Princeton 392
Izmir 373
Nanjing 322
Dearborn 227
Wilmington 223
Council Bluffs 206
Los Angeles 204
Santa Clara 193
Cambridge 187
Ho Chi Minh City 176
Ann Arbor 168
The Dalles 155
Altamura 151
Tongling 130
Boardman 124
New York 119
Buffalo 116
Nanchang 112
Hanoi 108
Munich 106
Woodbridge 96
Grevenbroich 73
Shenyang 73
Moscow 71
Chieti 70
Hong Kong 67
Houston 65
São Paulo 62
Hebei 59
Tianjin 53
Jiaxing 46
Washington 44
Jinan 42
Kunming 40
Montréal 37
Chennai 35
Denver 34
Orem 33
Seoul 33
Redondo Beach 32
Augusta 30
Warsaw 30
Brooklyn 29
Tokyo 29
Chicago 28
Hangzhou 28
Montreal 28
Pescara 28
Atlanta 27
Brussels 27
Da Nang 27
Johannesburg 27
Brno 26
Helsinki 26
Boston 25
Norwalk 25
Orange 25
San Mateo 24
Turku 24
Mcallen 23
Ningbo 22
Toronto 22
Zhengzhou 22
Hefei 21
Haiphong 20
London 20
Changsha 19
Mexico City 19
Milan 19
Phoenix 19
Rome 19
Seattle 19
Auburn Hills 17
Manchester 17
Poplar 17
Stockholm 17
Dong Ket 16
Belo Horizonte 15
Frankfurt am Main 15
San Francisco 15
Düsseldorf 14
Guangzhou 14
Hyderabad 14
Brasília 13
St Louis 13
Taizhou 13
Mumbai 12
Pune 12
Rio de Janeiro 12
Bangalore 11
Biên Hòa 11
Totale 13.557
Nome #
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 254
Vascular endothelial growth factor (VEGF), mast cells and inflammation 188
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 179
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 178
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 178
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 176
Anti-chemochine therapy for inflammatory diseases 175
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study 174
Allergen immunotherapy: an effective immune-modifier. 171
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 171
Caffeine, Theophylline and bamifylline are similar as competitive inhibitors of 3' ,5'-cyclic AMP phosphodiesterase in vitro 168
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 164
Heme Oxigenase-1 (HO-1) and oxidative stress in rat heart 162
A scavenger role for nitric oxide in the aged rat kidney. 161
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 160
A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application 160
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 159
Bamifylline similar to theophylline and caffeine is a competitive inhibitor of the cyclic nucleotide phosphodiesterase V 157
Nutrition and cancer prevention. 156
Activation and inhibition of adaptive immune response mediated by mast cells 153
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 151
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 151
Microarray expression profiling of human dental pulp from single subject. 150
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism 150
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 148
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 148
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. 148
ENOX2 (or tNOX): a new and old molecule with cancer activity involved in tumor prevention and therapy 146
Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 146
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. 144
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 142
Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury 141
Interleukin-9 and mast cells 140
Endocrinology of the skin: intradermal neuroimmune network, a new frontier 140
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 139
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 138
Impact of RANTES, MCP-1 and IL-8 in mast cells 138
ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY 137
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 137
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 137
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 136
Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study 136
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 136
A new diagnostic approach to better identify antiphospholipid syndrome. 135
Calcium ionophore A23187 and compound 48/80 induce PGD2 and tryptase in human cord blood-derived mast cells: lack of effect of il-18 135
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation 135
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 135
Chemokines as markers for parasite-induced inflammation and tumors 134
Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. 134
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 134
In vitro effects of vanadate on human immune functions 134
IL-10, an inflammatory/inhibitory cytokine, but not always. 133
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 133
Tridimensional response of human dental follicular stem cells onto a synthetic hydroxyapatite scaffold. 132
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 132
Interleukin-17 and the interleukin-17 family member network. 131
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 129
Morphostructural analysis of human follicular stem cells on highly porous bone hydroxyapatite scaffold. 129
Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. 128
Relevance of plant lectins in human cell biology and immunology 128
Effect of the compound L-mimosine in an in vivo model of chronic granuloma formation induced by potassium permanganate (KMNO4). 127
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 127
Production of cytokines in trichinellosis infected mice 126
Cytokines and allergic disorders: a revisited study 126
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 126
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 125
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 125
IL-36 a new member of the IL-1 family cytokines 125
Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue 124
IL-32: a newly-discovered proinflammatory cytokine 124
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 123
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 122
Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells 122
Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. 122
Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells. 122
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 121
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 121
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 121
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 121
Endothelial Nitric Oxide Synthase (e-NOS)expression and localization in healthy and diabetic rat hearts 121
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 121
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 120
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 120
Aluminum impairs rat neural cell mitochondria in vitro 120
Interleukin-17: a revisited study. 120
Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee 119
Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4 119
Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine. 118
Endothelial cells, cholesterol, cytokines, and aging 118
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 117
Infections and mast cells 117
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 116
NEUROLOGIC SOFT SIGNS IN SCHIZOPHRENIC PATIENTS TREATED WITH CONVENTIONAL AND ATYPICAL ANTIPSYCHOTICS 116
Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? 115
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 114
Irritable bowel syndrome and bronchial hyperresponsiveness: is there a link? 113
Endothelial NOS expression and ischemia- reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions 113
Periodontitis and cytokine patterns in HIV positive patients 113
Impact of IL-33 on PGD2 generation by activated human cord blood-derived mast cell: Lack of effect on tryptase release 113
Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis 113
Totale 13.780
Categoria #
all - tutte 85.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/2022789 28 13 4 166 64 3 16 64 54 26 104 247
2022/20232.982 258 380 181 360 328 587 162 194 373 34 62 63
2023/20241.135 95 40 66 38 63 314 313 37 19 21 13 116
2024/20253.225 234 596 579 59 69 89 47 148 281 139 364 620
2025/20266.426 539 312 752 736 568 469 1.052 445 638 501 352 62
Totale 22.410